Skip to content

Viridian Therapeutics, Inc. VRDN Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$189.67B+13.3%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$5.06B+74.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$1.72B+18.3%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.43B+61.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$2.06B+1,531%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06B+95.0%

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Computed from the period-end share price: $2B.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s market capitalization?
Viridian Therapeutics, Inc. (VRDN) reported market capitalization of $2B in Q1 2026.
How has Viridian Therapeutics, Inc.'s market capitalization changed year-over-year?
Viridian Therapeutics, Inc.'s market capitalization increased by 82.0% year-over-year, from $1.1B to $2B.
What is the long-term trend for Viridian Therapeutics, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s market capitalization has grown at a 95.4% compound annual growth rate (CAGR), from $104.23M to $2.97B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.